Target intelligence / Profile preview

Non-MYC mRNAs with seed-region complementarity

Molecular classification
Messenger RNA, Survival genes, Transcriptome subset
01

Overview

Non-MYC mRNAs with seed-region complementarity refers to a broad class of messenger RNAs that are targeted by small RNAs (siRNAs or shRNAs) through a mechanism involving partial sequence matches, specifically in the 6-8 nucleotide seed region (Gao et al., 2018). This interaction is the basis for Death Induced by Survival gene Elimination (DISE), a process where the simultaneous silencing of multiple genes essential for cell survival triggers extensive apoptosis in cancer cells (Putzbach et al., 2017). While this effect was historically viewed as an off-target complication in MYC-directed RNAi therapies, it has emerged as a potential therapeutic strategy due to its ability to kill cancer cells regardless of their genetic driver or resistance profile (Peter, 2017). The mechanism involves the RNA-induced silencing complex (RISC) binding to the 3' untranslated regions (UTRs) of these survival-critical mRNAs, leading to their degradation or translational inhibition (Hadji et al., 2014). However, the lack of specificity inherent in seed-based targeting poses significant safety challenges, as it can lead to non-selective cell death in healthy tissues if not precisely delivered (Gao et al., 2018).

Other names
DISE targetsSurvival gene transcripts6-mer seed-matched mRNAsOff-target survival genesDeath Induced by Survival gene Elimination targets
02

Mechanism of action

Seed-region dependent RNA interference (RNAi) leading to multi-gene silencing and Death Induced by Survival gene Elimination (DISE)

03

Biological functions

Cell survivalApoptosis regulationRNA interferenceGene expression regulation
04

Disease associations

Cancer
05

Safety considerations

Non-specific cytotoxicitySystemic off-target effectsDifficulty in therapeutic window definitionPotential for widespread tissue damage
06

Interacting drugs

siRNAs

3 more in the full profile.

07

Biomarkers

3' UTR seed match frequencySurvival gene expression profileSeed sequence G-richness

Beyond the preview

Go deeper on Non-MYC mRNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-MYC mRNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call